An investigation of the expression of G1-phase cell cycle proteins in focal cortical dysplasia type IIB

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 11, 2007, Pages 1045-1055

  Thom, Maria ^a,e   Martinian, Lillian ^a   Sen, Arjune ^a   Squier, W ^b   Harding, Brian N ^c   Cross, J H ^d   Harkness, William ^c   McEvoy, Andrew ^a   Sisodiya, Sanjay M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Balloon cells; Cell arrest; Focal cortical dysplasia; G1 phase

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DOPAMINE 1 RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CHILD; CONTROLLED STUDY; CORTICAL DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SENESCENCE; BRAIN; INFANT; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; NEURONS;

EID: 35848956323     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e3181598d23     Document Type: Article

References (41)

1. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-35
2. Palmini A, Najm I, Avanzini G. Terminology and classification of the cortical dysplasias. Neurology 2004;62(6 Suppl 3):S2-8
3. Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 2005;46:1716-23
4. Thom M, Martinian L, Sisodiya SM, et al. Mcm2 labeling of balloon cells in focal cortical dysplasia. Neuropathol Appl Neurobiol 2005;31:580-88
5. Fauser S, Becker A, Schulze-Bonhage A, et al. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol (Berl) 2004;108:272-78
6. Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene 2003;22:5208-19
7. Greene LA, Liu DX, Troy CM, Biswas SC. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim Biophys Acta 2007;1772:392-401
8. Herrup K, Neve R, Ackerman SL, Copani A. Divide and die: Cell cycle events as triggers of nerve cell death. J Neurosci 2004;24:9232-39
9. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-87
10. Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: Tissue microarray analysis. Ann Neurol 2004;56:510-19
11. Cotter DR, Honavar M, Everall I. Focal cortical dysplasia: A neuropathological and developmental perspective. Epilepsy Res 1999;36:155-64
12. Wharton SB, Hibberd S, Eward KL, et al. DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer 2004;91:262-69
13. Hoozemans JJ, Bruckner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol 2002;61:678-88
14. Bosone I, Cavalla P, Chiado-Piat L, Vito ND, Schiffer D. Cyclin D1 expression in normal oligodendroglia and microglia cells: Its use in the differential diagnosis of oligodendrogliomas. Neuropathology 2001;21:155-61
15. Lombroso CT. Can early postnatal closed head injury induce cortical dysplasia. Epilepsia 2000;41:245-53
16. Marin-Padilla M, Parisi JE, Armstrong DL, Sargent SK, Kaplan JA. Shaken infant syndrome: Developmental neuropathology, progressive cortical dysplasia, and epilepsy. Acta Neuropathol (Berl) 2002;103:321-32
17. da Silva AV, Regondi MC, Cavalheiro EA, Spreafico R. Disruption of cortical development as a consequence of repetitive pilocarpine-induced status epilepticus in rats. Epilepsia 2005;46(Suppl 5):22-30
18. Cepeda C, Hurst RS, Flores-Hernandez J, et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003;72:472-86
19. Schick V, Majores M, Fassunke J, et al. Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions. Neuropathol Appl Neurobiol 2007;33:152-62
20. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76
21. Genovese C, Trani D, Caputi M, Claudio PP. Cell cycle control and beyond: Emerging roles for the retinoblastoma gene family. Oncogene 2006;25:5201-9
22. Maiorano D, Lutzmann M, Mechali M. MCM proteins and DNA replication. Curr Opin Cell Biol 2006;18:130-36
23. De Rosa MJ, Farrell MA, Burke MM, Secor DL, Vinters HV. An assessment of the proliferative potential of "balloon cells" in focal cortical resections performed for childhood epilepsy. Neuropathol Appl Neurobiol 1992;18:566-74
24. Lukas C, Falck J, Bartkova J, Bartek J, Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat Cell Biol 2003;5:255-60
25. Houtgraaf JH, Versmissen J, van der Giessen WJ. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 2006;7:165-72
26. Blagosklonny MV. Cell senescence: Hypertrophic arrest beyond the restriction point. J Cell Physiol 2006;209:592-97
27. Ljungberg MC, Bhattacharjee MB, Lu Y, et al. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 2006;60:420-29
28. Schick V, Majores M, Engels G, et al. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. Acta Neuropathol (Berl) 2006;112:715-25
29. 1 cell cycle progression. Mol Syst Biol 2007;3:84
30. Boylan JF, Sharp DM, Leffet L, Bowers A, Pan W. Analysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression. Exp Cell Res 1999;248:110-14
31. Paternot S, Arsenijevic T, Coulonval K, Bockstaele L, Dumont JE, Roger PP. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: Differential involvement in the distinct mitogenic modes of thyroid epithelial cells. Cell Cycle 2006;5:61-70
32. Murray AW. Recycling the cell cycle: Cyclins revisited. Cell 2004;116:221-34
33. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005;24:2776-86
34. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA. Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 2003;22:8723-30
35. Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 2006;24:185-97
36. Okorokov AL, Orlova EV, Kingsbury SR, et al. Molecular structure of human geminin. Nat Struct Mol Biol 2004;11:1021-22
37. Chia W, Prokopenko SN. Cyclin E at the centre of an identity crisis. Nat Cell Biol 2005;7:3-5
38. Khidr L, Chen PL. RB, the conductor that orchestrates life, death and differentiation. Oncogene 2006;25:5210-19
39. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM. Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol (Berl) 2005;110:383-92
40. Andres M, Andre VM, Nguyen S, et al. Human cortical dysplasia and epilepsy: An ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. Cereb Cortex 2005;15:194-210
41. Rashidian J, Iyirhiaro G, Aleyasin H, et al. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc Natl Acad Sci USA 2005;102:14080-85